Deutsch English Français

Contact

EP0955301

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0955301

EP0955301 - 7-aza-bicyclo 2.2.1 -heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors [Right-click to bookmark this link]
Former [1999/45]	7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
	[1999/47]
Status	The application is deemed to be withdrawn Status updated on 15.02.2008 Database last updated on 19.10.2024
Most recent event Tooltip	15.02.2008	Application deemed to be withdrawn	published on 19.03.2008 [2008/12]
Applicant(s)	For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US
	[N/P]
Former [1999/45]	For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US
Inventor(s)	01 / Yohannes, Daniel 600 Meridian Street Ext. No. 403 Groton, Connecticut 06340 / US
	02 / Bundesmann, Mark Werner 61 East Main Street Mystic, Connecticut 06355 / US
	[1999/45]
Representative(s)	O'Brien, Niall James, et al Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER / GB
	[N/P]
Former [2006/09]	O'Brien, Niall James, et al Urquhart-Dykes & Lord LLP 30 Welbeck Street GB-London W1G 8ER / GB
Former [1999/45]	Simpson, Alison Elizabeth Fraser, et al Urquhart-Dykes & Lord, 91 Wimpole Street London W1M 8AH / GB
Application number, filing date	99302306.8	25.03.1999
	[1999/45]
Priority number, date	US19980083108P	27.04.1998 Original published format: US 83108 P
	[1999/45]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0955301
	Date:	10.11.1999
	Language:	EN
	[1999/45]
	Type:	A3 Search report
	No.:	EP0955301
	Date:	18.04.2001
	[2001/16]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	28.02.2001
Classification	IPC:	C07D487/08, A61K31/40, A61K31/44, A61K31/41, A61K31/505, // (C07D487/08, 209:00, 209:00)	[2000/48]
	CPC:	C07D487/08 (EP,US); A61P1/00 (EP); A61P1/04 (EP); A61P21/00 (EP); A61P25/00 (EP); A61P25/04 (EP); (+) A61P25/06 (EP); A61P25/08 (EP); A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP); A61P25/34 (EP); A61P29/00 (EP); A61P29/02 (EP); A61P3/00 (EP); A61P3/04 (EP); A61P35/00 (EP); A61P9/00 (EP); A61P9/06 (EP); A61P9/12 (EP); Y02P20/55 (EP,US) (-)
	Former IPC [1999/45]	C07D487/08, A61K31/44, // (C07D487/08, 209:00, 209:00)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2002/02]
Former [1999/45]	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE
Title	German:	7-Aza-bicyclo 2.2.1 -heptan Derivate, deren Herstellung und Verwendung aufgrund ihrer Affinität für neuronale nikotinische Acetylcholin Rezeptoren	[2007/46]
	English:	7-aza-bicyclo 2.2.1 -heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors	[2007/46]
	French:	Dérivés de 7-aza-bicyclo 2.2.1 -heptane, leur préparation et utilisation sur la base d'affinité pour les recepteurs de l'acetylcholine nicotinique neuronaux	[2007/46]
	Former [1999/45]	7-Aza-bicyclo[2.2.1]-heptan Derivate, deren Herstellung und Verwendung aufgrund ihrer Affinität für neuronale nikotinische Acetylchlolin Rezeptoren
	Former [1999/45]	7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylchloline receptors
	Former [1999/45]	Dérivés de 7-aza-bicyclo[2.2.1]-heptane, leur préparation et utilisation sur la base d'affinité pour les récepteurs de l'acetylchloline nicotinique neuronaux
Examination procedure	12.04.1999	Examination requested [1999/45]
	25.11.2002	Despatch of a communication from the examining division (Time limit: M06)
	03.06.2003	Reply to a communication from the examining division
	05.11.2003	Despatch of a communication from the examining division (Time limit: M06)
	20.08.2004	Reply to a communication from the examining division
	03.03.2005	Despatch of a communication from the examining division (Time limit: M06)
	22.12.2005	Reply to a communication from the examining division
	02.10.2007	Application deemed to be withdrawn, date of legal effect [2008/12]
	05.11.2007	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2008/12]
Request for further processing for:	22.12.2005	Request for further processing filed
	22.12.2005	Full payment received (date of receipt of payment) Request granted
	13.01.2006	Decision despatched
	20.08.2004	Request for further processing filed
	20.08.2004	Full payment received (date of receipt of payment) Request granted
	03.09.2004	Decision despatched
Fees paid	Renewal fee
	27.01.2001	Renewal fee patent year 03
	10.01.2002	Renewal fee patent year 04
	22.01.2003	Renewal fee patent year 05
	06.02.2004	Renewal fee patent year 06
	29.01.2005	Renewal fee patent year 07
	13.01.2006	Renewal fee patent year 08
	Penalty fee
	Additional fee for renewal fee
	31.03.2007	09 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9318037 (US HEALTH [US]) [X] 1-4,7,8 * claims 2,5,7 *;
		[DX]WO9422868 (UNIV VIRGINIA [US], et al) [DX] 1-3,7,8 * examples 25,40,44,54-56,60,63,64; claims 1-9,14-27,42-46 *;
		[DX]WO9503306 (DU PONT [US], et al) [DX] 1 * claims 1,5,10 *;
		[D]JPH0761940 (EISAI CO LTD) [D] * column 12 - column 13 * * column 16 * * column 18 - column 22 *;
		[DX]WO9507078 (CYTOMED INC [US], et al) [DX] 1-8 * claims 1-3,7-9,12-14; table I *;
		[DX]EP0657455 (EGYT GYOGYSZERVEGYESZETI GYAR [HU]) [DX] 1-4,7,8 * examples 12,19,26,33,42,48; claims 1-5,15,16 *;
		[DX]EP0664293 (DUPHAR INT RES [NL]) [DX] 1-4,7,8 * page 2, line 25 - line 26; example I; claims 1-4 *;
		[DX]WO9606093 (UNIV VIRGINIA [US], et al) [DX] 1-3,7,8 * figures 3,4,6; examples 25,40,44,54-56,60,81,82,84-90,93-95; claims 1-3,5-7,14-25,27-30,32-34 *;
		[PX]WO9846609 (ABBOTT LAB [US]) [PX] 1,5,7 * claims 1-8,13,14 *;
		[X] - AKASAKA, K. ET AL., "Preparation of azabicycloheptane derivatives and their use as pharmaceuticals including analgesics", CHEMICAL ABSTRACTS, (19950911), vol. 123, no. 11, Database accession no. 132885k, page 130, column 1, XP002149521 [X] 1-4,7,8 * abstract *
		[A] - HUISGEN R. ET AL., "1-Pyrrolines and 7-azabicyclo[2.2.1]heptane from azlactones and activated alkenes", CHEMISCHE BERICHTE, VERLAG CHEMIE GMBH. WEINHEIM, DE, (1970), vol. 103, no. 8, pages 2368 - 2387, XP000984022 [A] 1 * compounds 17, 19, 24, 26, 40 *
		[A] - MARCHAND A.P. & ALLEN R.W., "Synthesis of 7-azanorbornene and N-methyl-7-azanorbornene", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, (1975), vol. 40, no. 17, pages 2551 - 2552, XP000941118 [A] 9-11 * scheme I, compound 8 * DOI: http://dx.doi.org/10.1021/jo00905a037

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p